Autoimmune Polyglandular Syndrome Type 2 (APS-2)
What is APS-2?
APS-2 (Schmidt Syndrome) is the most common autoimmune polyglandular syndrome, characterized by Addison's disease (adrenal insufficiency) combined with either autoimmune thyroid disease and/or type 1 diabetes. It typically presents in adulthood.
Diagnostic Criteria (Must Have Addison's + At Least One Other):
- Addison's Disease (100% - Required): Primary adrenal insufficiency
- PLUS one or both of:
- Autoimmune Thyroid Disease (70-80%): Hashimoto's thyroiditis or Graves' disease
- Type 1 Diabetes (30-50%)
Other Associated Conditions:
- Primary Hypogonadism
- Celiac Disease (common)
- Pernicious Anemia
- Vitiligo (10-20%)
- Myasthenia Gravis
- Alopecia Areata
Key Differ ences from APS-1:
- Age of Onset: Adulthood (20s-40s) vs. childhood (APS-1)
- Genetics: Polygenic/HLA-associated vs. single gene (AIRE) in APS-1
- More Common: 1-2 per 100,000 vs. very rare APS-1
- NO Candidiasis or Hypoparathyroidism (unlike APS-1)
- Female Predominance: 3:1 female:male ratio
Diagnosis & Management:
- Screen for Other Autoimmune Diseases: Once one is diagnosed
- Annual Surveillance: TSH, fasting glucose, celiac screening
- Hormone Replacement:
- Hydrocortisone (for Addison's)
- Levothyroxine (if hypothyroid)
- Insulin (if diabetic)
- Emergency Precautions: Steroid emergency card, stress dosing education
- Family Screening: Siblings have increased risk
Key Points:
- APS-2 = Addison's disease + autoimmune thyroid disease and/or type 1 diabetes
- Most common polyglandular syndrome
- Adult onset (20s-40s)
- Lifelong surveillance for additional autoimmune conditions
- Requires multiple hormone replacements